Anti-Contactin-associated protein-like 2 antibodies (IgG + IgA)

Optimal Result: 0 - 10 Units.

Anti-Contactin-associated protein-like 2 (CASPR2) antibodies, including both IgG and IgA classes, are autoantibodies targeting the CASPR2 protein, a component of the voltage-gated potassium channel complex located in the nervous system. The presence of these antibodies is associated with a spectrum of neurological conditions, often termed CASPR2-antibody associated syndromes, which include neuromyotonia (also known as Isaac's syndrome), Morvan syndrome, and autoimmune forms of limbic encephalitis.

Patients with anti-CASPR2 antibodies can present with various symptoms depending on the affected region of the nervous system. In neuromyotonia, symptoms may include muscle twitching, cramps, and stiffness, whereas limbic encephalitis is characterized by memory loss, confusion, seizures, and sometimes psychiatric symptoms. Morvan syndrome is distinguished by a combination of neuromyotonia and encephalitis symptoms, along with autonomic dysfunction like sleep disturbances, sweating, and cardiac irregularities.

The dual presence of IgG and IgA anti-CASPR2 antibodies can have different pathological implications. IgG antibodies are generally considered to be pathogenic, disrupting ion channels and associated proteins, leading to neuronal hyperexcitability or synaptic dysfunction. The role of IgA antibodies in neurological diseases is less clear but is an active area of research. The combination of both antibody types may suggest a robust or complex autoimmune response and might influence the severity of the disease or response to therapy.

Diagnosing CASPR2-associated syndromes often involves the detection of these antibodies in the serum or cerebrospinal fluid (CSF). The detection serves not only for diagnosis but also for indicating a potential paraneoplastic etiology, as these antibodies can be associated with tumors, particularly thymomas.

Treatment strategies for conditions associated with anti-CASPR2 antibodies include immunotherapies such as corticosteroids, plasmapheresis, immunoglobulins, and immunosuppressants. In cases where a tumor is present, treatment also involves addressing the neoplasm. Monitoring the levels of anti-CASPR2 antibodies can be part of the management, helping to gauge the effectiveness of these therapies.

In summary, the presence of anti-CASPR2 antibodies, both IgG and IgA, is a critical marker for a variety of autoimmune neurological conditions. Their detection helps in diagnosing complex syndromes, suggests possible underlying malignancies, and informs a tailored approach to treatment, which is crucial given the potential for these disorders to be both severe and treatable.

10 000+ happy customers
100% satisfaction
★ ★ ★ ★ ★ customer support

Trust us to examine your lab results, guiding you towards improved health.

Use promo code to save 10% off any plan.

We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.